SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 25 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $0 | – | 247 | +366.0% | 0.00% | – |
| Q1 2024 | $0 | – | 53 | -90.1% | 0.00% | – |
| Q4 2023 | $0 | – | 538 | +117.8% | 0.00% | – |
| Q3 2023 | $0 | -100.0% | 247 | -47.7% | 0.00% | – |
| Q2 2023 | $1,000 | – | 472 | +673.8% | 0.00% | – |
| Q1 2023 | $0 | – | 61 | +1425.0% | 0.00% | – |
| Q4 2022 | $0 | – | 4 | -94.8% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 77 | -94.0% | 0.00% | – |
| Q1 2022 | $3,000 | -88.5% | 1,284 | -70.4% | 0.00% | – |
| Q4 2021 | $26,000 | +4.0% | 4,343 | +80.1% | 0.00% | – |
| Q3 2021 | $25,000 | +257.1% | 2,411 | +255.1% | 0.00% | – |
| Q2 2021 | $7,000 | -36.4% | 679 | -7.6% | 0.00% | – |
| Q1 2021 | $11,000 | – | 735 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 650,000 | $403,065 | 0.07% |
| Deuterium Capital Management, LLC | 11,000 | $6,821 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 172,835 | $107,175 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 77,900 | $48,306 | 0.00% |
| XTX Topco Ltd | 14,047 | $8,711 | 0.00% |
| Leo Wealth, LLC | 14,845 | $9,205 | 0.00% |
| NORTHERN TRUST CORP | 25,983 | $16,112 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Cresset Asset Management, LLC | 19,671 | $12,198 | 0.00% |
| Banque Cantonale Vaudoise | 3,900 | $2 | 0.00% |